Peripheral Vascular Clot Management Interventions Market 2030

Peripheral Vascular Clot Management Interventions Market By Product Type (Catheters [Thrombolytic Catheters, Aspiration Catheters, And Embelectomy Catheters], Stent Retrievers, Inferior Vena Cava Filters, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others) and geography is expected to grow at a steady CAGR forecast till 2030 owing increasing prevalence of cardiovascular diseases such as strokes, pulmonary embolism, and others, along with the rising geriatric population around the globe during the forecast period.

The global Peripheral Vascular Clot Management Interventions market is estimated to grow at a CAGR of 7.43% during the forecast period from 2024 to 2030. The demand for Peripheral Vascular Clot Management Interventions is primarily being boosted owing to the increasing prevalence of cardiovascular diseases such as strokes, pulmonary embolism, and others, rise in the number of lifestyle disorders such as hypertension and obesity among others, thereby contributing to the overall growth of the Peripheral Vascular Clot Management Interventions market during the forecast period from 2024-2030.

Peripheral Vascular Clot Management Interventions Market Dynamics:

According to the factsheet on cardiovascular diseases by the World Health Organization (2022), it stated that more than four-fifths of deaths from cardiovascular diseases globally are primarily due to stroke and heart attack, and one-third of these deaths affect people under the age of 70. Aging is considered as a major risk factor for numerous diseases as well as increasing the chances of developing thrombosis such as deep vein thrombosis (DVT). One of the major complications of DVT is pulmonary embolism, which can be fatal to the patient. 

Therefore, in order to avoid the serious consequences of thrombosis, devices for clot intervention management such as catheters, inferior vena cava filters, and others are used, among other intervention devices. Therefore, an increase in the elderly population, which may lead to an increase in the cases of DVT may further drive the demand for interventional devices, thus contributing to the growth of the peripheral vascular clot management interventions market in the upcoming years.

Hence, the interplay of all the above-mentioned factors is anticipated to increase the overall market growth for Peripheral Vascular Clot Management Interventions during the forecast period from 2024-2030.

However, the high cost associated with clot interventions, device complications, and frequent product recalls among others may restrict the growth of the overall market for peripheral vascular clot management interventions during the forecast period.

Peripheral Vascular Clot Management Interventions Market Segment Analysis:

Peripheral Vascular Clot Management Interventions market by Product Type (Catheters [Thrombolytic Catheters, Aspiration Catheters, And Embelectomy Catheters], Stent Retrievers, Inferior Vena Cava Filters, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others) And Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the Peripheral Vascular Clot Management Interventions market, the stent retrieval category is expected to amass a significant revenue share in the year 2023. This can be ascribed to their various advantages in stroke patients as compared to medical therapy alone. For instance, the advantages such as mechanical thrombectomy with stent retrievers is reported to produce a superior clinical outcome in patients. In addition to that, stent retrievers have a safety profile similar to that of systemic thrombolytic therapy.

In addition, advances in product design such as the integration of platinum for improved visibility and for longer lengths up to 40 mm have helped in improving the first-pass reperfusion outcomes. The entry of recoverable self-expanding thrombectomy devices further offer advantages, such as these devices restore flow immediately and avoid the placement of a permanent stent, by immediately restoring blood flow and eliminating the need for the placement of a permanent stent, thus reducing the chances of in-stent restenosis. Owing to all the factors mentioned above, it is expected that the demand for stent retrieval devices is going to increase further, ultimately driving the Peripheral Vascular Clot Management Interventions market forward.

Moreover, in February 2022, MicroPort NeuroTech Limited received marketing approval from China’s National Medical Products Administration (NMPA) for its self-developed Neurohawk® Stent Thrombectomy Device (Neurohawk®), which is a retrievable, self-expandable clot stent retriever used in endovascular invasive thrombectomy procedures to remove large clots in blood vessels. 

Therefore, considering the advantages associated with stent retrieval devices in cardiovascular clot management procedures and its recent approvals, it is expected to contribute to the overall market growth for Peripheral Vascular Clot Management Interventions during the forecast period from 2024 to 2030.

North America Is Expected To Dominate The Overall Peripheral Vascular Clot Management Interventions Market:

Among all the regions, North America is estimated to account for the largest share of the Peripheral Vascular Clot Management Interventions market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of DVT, and embolism, due to the increasing prevalence of obesity, hypertension, and diabetes, the aging population, the growing prevalence of cancers, government initiatives regarding clot interventions and treatment awareness, the North America market is expected to witness positive growth in the upcoming years. Furthermore, the high disposable income, sophisticated healthcare infrastructure, new product approvals, among other factors have also helped the market growth in this region.

As per the latest data provided by the American Cancer Society (2022), around 1.9 million new cancer cases were diagnosed and 608,570 cancer deaths were reported in the United States in 2021. Cancer patients are observed to have specific abnormal coagulation factors which increase the chances of thrombus formation. In addition, chemotherapy is also related to an increased risk of venous thrombosis resulting in deep vein thrombosis. Therefore, the rising prevalence of cancers in the US is expected to aid in the growing need for clot intervention devices thereby resulting in an increased in product demand aiding in the growth of the United States clot management devices market.

Moreover, as per data provided by the Canadian government (2023), in 2019, based on the body-mass index, approximately 56.5% of the Canadian population across all age groups were obese. Obesity is one of the most common factors that may result in embolism or DVT. Furthermore, obesity is also related with the inefficacy of anticoagulation therapeutics in obese patients. 

Therefore, the presence of a large patient population suffering from obesity is related to the presence of a high patient population suffering from as strokes, embolism, and DVT which would indicate the growing need for clot management equipment, thereby resulting in an increase in product demand supporting the growth of the North America Peripheral Vascular Clot Management Interventions market during the forecast period.

Peripheral Vascular Clot Management Interventions Market Key Players:

Some of the key market players operating in the Peripheral Vascular Clot Management Interventions market include Abbott, Edwards Lifesciences, Medtronic, Teleflex Incorporated, Boston Scientific Corporation, Biotronik, Merit Medical, B. Braun SE, Terumo Corporation, Penumbra Inc., MicroPort Scientific Corporation, Johnson and Johnson Services, Inc., Inari Medical, Acandis GmbH & Co. KG, AngioDynamics, Argon Medical Devices, Inc., Boston Scientific Corporation, Control Medical Technology, Innova Vascular, Inc., Thrombolex, Inc., and others.

Recent Developmental Activities In The Peripheral Vascular Clot Management Interventions Market:

• In June 2023, Penumbra, Inc. announced the launch and approval by the U.S. Food and Drug Administration (FDA) for its Lightning Bolt™ 7, an advanced and powerful arterial thrombectomy system that introduced a new method for removing blood clots, modulated aspiration, pairing Penumbra’s Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm. Lightning Bolt 7 is designed to enhance the ability to rapidly remove large, fibrous blood clots in the arteries with minimal blood loss.
• In September 2021, Abbott announced the acquisition of Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.
• In September 2020, CERENOVUS, a Johnson & Johnson Medical Devices Company, announced the launch of CERENOVUS Stroke Solutions™, designed to aid physicians in clot removal procedures. The CERENOVUS Stroke Solutions™ were designed with compatibility to help physicians perform mechanical thrombectomy procedures, consisting of the CEREBASE™ DA Guide Sheath, CERENOVUS Large Bore Catheter, and the EMBOTRAP® III Revascularization Device.

Key Takeaways From The Peripheral Vascular Clot Management Interventions Market Report Study

• Market size analysis for current Peripheral Vascular Clot Management Interventions market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Peripheral Vascular Clot Management Interventions market.
• Various opportunities available for the other competitors in the Peripheral Vascular Clot Management Interventions market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Peripheral Vascular Clot Management Interventions market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Peripheral Vascular Clot Management Interventions market growth in the coming future?

Target Audience Who Can Benefit From This Peripheral Vascular Clot Management Interventions Market Report Study

• Peripheral Vascular Clot Management Interventions product providers
• Research organizations and consulting companies 
• Peripheral Vascular Clot Management Interventions-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Peripheral Vascular Clot Management Interventions 
• Various end-users who want to know more about mental disorders and its related treatment equipment market, along with the latest technological developments in the Peripheral Vascular Clot Management Interventions market.

Frequently Asked Questions For The Peripheral Vascular Clot Management Interventions Market:

1. What is meant by Peripheral Vascular Clot Management Interventions?

Peripheral Vascular Clot Management Interventions help in the management of clots in blood vessels outside the heart without making large incisions. This minimally invasive approach helps in the treatment of people leading to faster recoveries with less pain, along with lower risk of complications and a shorter hospital stays.

2. What is the market for global Peripheral Vascular Clot Management Interventions?

The global Peripheral Vascular Clot Management Interventions market is estimated to grow at a CAGR of 7.43% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Peripheral Vascular Clot Management Interventions market?

The demand for Peripheral Vascular Clot Management Interventions is primarily being boosted owing to the increasing prevalence of cardiovascular diseases such as strokes, pulmonary embolism, and others, rise in the number of lifestyle disorders such as hypertension and obesity among others, thereby contributing to the overall growth of the Peripheral Vascular Clot Management Interventions market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Peripheral Vascular Clot Management Interventions market?

Some of the key market players operating in the Peripheral Vascular Clot Management Interventions market include Abbott, Edwards Lifesciences, Medtronic, Teleflex Incorporated, Boston Scientific Corporation, Biotronik, Merit Medical, B. Braun SE, Terumo Corporation, Penumbra Inc., MicroPort Scientific Corporation, Johnson and Johnson Services, Inc., Inari Medical, Acandis GmbH & Co. KG, AngioDynamics, Argon Medical Devices, Inc., Boston Scientific Corporation, Control Medical Technology, Innova Vascular, Inc., Thrombolex, Inc., and others.

5. Which region has the highest share in the Peripheral Vascular Clot Management Interventions market?

North America is estimated to account for the largest share of the Peripheral Vascular Clot Management Interventions market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of DVT, and embolism, due to the increasing prevalence of obesity, hypertension, and diabetes, the aging population, the growing prevalence of cancers, government initiatives regarding clot interventions and treatment awareness, the North America market is expected to witness positive growth in the upcoming years. Furthermore, the high disposable income, sophisticated healthcare infrastructure, new product approvals, among other factors have also helped the market growth in this region.